YanAn Bicon Pharmaceutical Listed Co. engages in the production and sale of fine chemicals and pharmaceuticals. It operates through the following business segments: Medicine, New energy and new materials, and Drug intermediates. The Medicine segment includes medicine for the circulatory, digestive, and respiratory systems as well as anti-infection, anti-tumor, and anti-rheumatism medicine. The New energy and new materials segment produces lithium hexafluorophosphate used as electrolyte solute for lithium batteries. The Drug intermediates segment includes sodium trichloropyridine and benzaldehyde. The company was founded on December 30, 2002 and is headquartered in Xinyi, China.